Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)

Kyung Nam Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	43,261	62,596	59,868	82,676	88,518	140,585
Market Cap Growth	-9.99%	4.56%	-27.59%	-6.60%	-37.04%	-17.15%
Enterprise Value	44,030	69,553	82,641	73,133	109,068	157,440
Last Close Price	2205.00	4005.00	6728.67	10721.07	15611.41	28500.11

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
PE Ratio	-	6.21	-	-	-	-
Forward PE	-	12.72	12.72	12.72	12.72	12.72
PS Ratio	0.79	1.03	1.01	1.40	1.37	1.98
PB Ratio	-	0.54	0.67	0.88	1.22	2.45
P/TBV Ratio	-	0.55	0.86	0.89	1.24	2.48
P/OCF Ratio	6.61	34.05	86.35	1155.05	-	53.76

EV Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
EV/Sales Ratio	0.78	1.14	1.39	1.24	1.69	2.22
EV/EBITDA Ratio	16.17	31.16	-	-	-	38.38
EV/EBIT Ratio	66.19	-	-	-	-	61.11

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Debt / Equity Ratio	-	0.33	0.57	0.35	0.55	0.72
Debt / EBITDA Ratio	-	16.84	-	-	-	10.09
Net Debt / Equity Ratio	-	-0.11	0.18	-0.13	0.22	0.24
Net Debt / EBITDA Ratio	-	-5.93	-22.07	8.47	-2.35	3.39
Net Debt / FCF Ratio	-	2.84	-1.01	4.42	-1.40	-0.32
Asset Turnover	-	0.37	0.39	0.45	0.51	0.71
Inventory Turnover	-	3.39	3.07	3.21	3.69	4.39
Quick Ratio	-	1.41	0.81	1.35	1.56	1.22
Current Ratio	-	1.68	1.03	1.70	2.16	1.49
Return on Equity (ROE)	-	-3.98%	-10.42%	-9.41%	-4.94%	-8.66%
Return on Assets (ROA)	-	-0.09%	-1.47%	-1.62%	-4.34%	1.60%
Return on Invested Capital (ROIC)	-	-0.23%	-3.84%	-4.01%	-10.94%	4.70%
Return on Capital Employed (ROCE)	-	-0.20%	-3.60%	-3.60%	-8.80%	2.90%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Earnings Yield	-11.84%	16.10%	-35.07%	-9.47%	-3.86%	-3.90%
FCF Yield	3.78%	-7.43%	-26.94%	-3.36%	-13.16%	-30.56%
Buyback Yield / Dilution	-25.37%	-22.60%	-21.50%	-27.71%	-32.46%	-11.06%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error